Published on
June 18, 2024
- 12:00 GMT
Ymmunobio and EVIIVE announce collaboration to develop advanced liquid biopsy for detecting NPTXR in cancer patients
Ymmunobio and EVIIVE collaborate to develop an innovative liquid biopsy using extracellular vesicles, enhancing precision in disease detection and monitoring. RIEHEN, SWITZERLAND, June 18, 2024 /EINPresswire.com/ -- Ymmunobio and EVIIVE are pleased to …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
